Nucleic acids encoding chimeric CD154 polypeptides

Details Nucleic acids encoding chimeric CD154 polypeptides Nucleic acids encoding chimeric CD154 polypeptides

2011-04-19

2011-04-19

Gambel, Phillip (Department: 1644)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023100, C536S023500, C435S252300, C435S320100, C435S455000

Reexamination Certificate

active

07928213

ABSTRACT:
The present invention provides for an isolated polynucleotide sequence encoding a chimeric CD154, comprising a first nucleotide sequence encoding an extracellular subdomain of non-human CD154, preferably murine CD154, that replaces a cleavage site of human CD154, and a second nucleotide sequence encoding an extracellular subdomain of human CD154 that binds to a human CD154 receptor. The present invention also provides for the chimeric CD154 that is encoded by the above-described polynucleotide sequence, an expression vector and a genetic vector comprising the polynucleotide sequence, a host cell comprising the expression vector or the genetic vector, a process for producing the chimeric CD154, and methods for utilizing the expression vectors and genetic constructs containing the chimeric CD154 polynucleotide sequences.

REFERENCES:
patent: 5716805 (1998-02-01), Srinivasan et al.
patent: 5817516 (1998-10-01), Kehry et al.
patent: 5861310 (1999-01-01), Freeman et al.
patent: 5962406 (1999-10-01), Armitage et al.
patent: 6451759 (2002-09-01), Kang et al.
patent: 6544523 (2003-04-01), Chu
patent: 7070771 (2006-07-01), Kipps et al.
patent: 7495090 (2009-02-01), Prussak et al.
patent: 2002/0022017 (2002-02-01), Yu
patent: 2004/0209295 (2004-10-01), Schwabe et al.
patent: 2005/0158831 (2005-07-01), Kornbluth
patent: 0 317 641 (1989-05-01), None
patent: 0 675 200 (1995-10-01), None
patent: 1 016 721 (2000-07-01), None
patent: WO 91/02540 (1991-03-01), None
patent: WO 93/08207 (1993-04-01), None
patent: WO 94/04680 (1994-03-01), None
patent: WO 94/17196 (1994-08-01), None
patent: WO 95/14487 (1995-06-01), None
patent: WO 95/18819 (1995-07-01), None
patent: WO 95/32627 (1995-12-01), None
patent: WO 96/14876 (1996-05-01), None
patent: WO 96/18413 (1996-06-01), None
patent: WO 96/22370 (1996-07-01), None
patent: WO 98/21232 (1998-05-01), None
patent: WO 98/21232 (1998-05-01), None
patent: WO 98/26061 (1998-06-01), None
patent: WO 98/26061 (1998-06-01), None
Addison, Christina L. et al., “Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model”,Proc. Natl. Acad. Sci. U.S.A., 92:8522-8526 (1995).
Alderson et al., “CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40”, J. Exp. Med., 178:669-674 (1993).
Ali, Munaf et al., “The use of DNA viruses as vectors for gene therapy”,Gene Therapy, 1:367-384 (1994).
Ali, Stuart Alvaro et al., “PCR-Ligation-PCR Mutagenesis: A Protocol for Creating Gene Fusions and Mutations”,Bio Techniques, 18:746-750 (1995).
Armitage et al., “CD40 ligand is a T cell growth factor”,Eur. J. Immunol., 23:2326-2331 (1993).
Armitage, Richard J. et al., “Molecular and biological characterization of a murine ligand for CD40”,Nature, 357:80-82 (1992).
Aruffo et al., “The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-Igfvl syndrome”,Cell, 72:291-300 (1993).
Attwood, T.K., “The Babel of Bioinformatics”,Science, 290:471-473 (2000).
Banchereau et al., “The CD40 antigen and its ligand”,Annual Review Immunol., 12:881-922 (1994).
Banchereau, Jacques et al., “Long-Term Human B Cell Lines Dependent on Interleukin-4 and Antibody to CD40”,Science, 251:70-72 (1991).
Berman, Joan W. et al., “Gene transfer in lymphoid cells: Expression of the Thy-1,2 antigen by Thy-1.1 BW5147 lymphoma cells transfected with unfractionated cellular DNA”,Proc. Natl. Acad. Sci. USA, 81:7176-7179 (1984).
Black et al., “A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells”,Nature, 385(6618):729-33 (1997).
Blieden, Timothy M. et al., “Class-I MHC Expression in the Mouse Lung Carcinoma, Line 1: A Model for Class-I Inducible Tumors”,Int. J. Cancer Supp., 6:82-89 (1991).
Boles, Eckhard et al., “A rapid and highly efficient method for PCR-based site-directed mutagenesis using only one new primer”,Curr. Genet., 28:197-198 (1995).
Boris-Lawrie, Kathleen A. et al., “Recent advances in retrovirus vector technology”,Current Opinion in Genetics and Development, 3:102-109 (1993).
Brody, Steven L. et al., “Adenovirus-mediated in Vivo Gene Transfer”,Ann. N. Y. Acad. Sci., 716:90-103 (1994).
Cadwell, R. Craig et al., “Randomization of Genes by PCR Mutagenesis”,PCR Methods and Applications, 2:28-33 (1992).
Cantwell et al., “Acquired CD40-ligand deficiency in chronic lymphocytic leukemia”,Nat. Med., 3:984-989 (1997).
Cantwell et al., “Membrane-Stabilizing Chimeric Tumor Necrosis Factor for Gene Therapy of B Cell Malignancies”,Blood, 98(11 Part 1):423a (2001).
Cantwell, M.J. et al., “CD95 and FAS-ligand expression and apoptosis in rheumatoid arthritis”,Arthritis and Rheumatism, 39(9), Suppl.:287 (1996).
Cantwell, Mark J. et al., “Adenovirus Vector Infection of Chronic Lymphocytic Leukemia B Cells”,Blood, 88:4676-4683 (1996).
Carter, Barrie J., “Adeno-associated virus vectors”,Current Opinion in Biotechnology, 3:533-539 (1992).
Castle et al., “Regulation of expression of the ligand for CD40 on T helper lymphocytes”,J. Immunol., 151:1777-1788 (1993).
Clark, Edward A. et al., “Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50”,Proc. Natl. Acad. Sci. U.S.A., 83:4494-4498 (1986).
Cooper, Mark J., “Noninfectious Gene Transfer and Expression Systems for Cancer Gene Therapy”,Seminars in Oncology, 23:172-187 (1996).
Cosman, David et al., “Cloning, sequence and expression of human interleukin-2 receptor”,Nature, 312:768-771 (1984).
Danko, Istvan et al., “Direct gene transfer into muscle”,Vaccine, 12:1499.1502 (1994).
Davis, Heather L. et al., “Direct Gene Transfer into Skeletal Muscle in Vivo: Factors Affecting Efficiency of Transfer and Stability of Expression”,Human Gene Therapy, 4:151-159 (1993).
Deans, Robert J. et al., “Expression of an immunoglobulin heavy chain gene transfected into lymphocytes”,Proc. Natl. Acad. Sci. USA, 81:1292-1296 (1984).
Decoster et al., “Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor”,J. Biol. Chem., 270(31):18473-8 (1995).
DeMatteo, Ronald P. et al., “Gene Transfer to the Thymus”,Annals of Surgery, 222:229-242 (1995).
Dilloo et al., “CD40 ligand induces an antileukemia immune response in vivo”,Blood, 90:1927-1933 (1997).
Evans, Christopher et al., “Clinical Trial to Assess the Safety, Feasibility, and Efficacy of Transferring a Potentially Anti-Arthritic Cytokine Gene to Human Joints with Rheumatoid Arthritis”,Human Gene Therapy, 7:1261-1280 (1996).
Fanslow, William C. et al., “Structural characteristics of CD40 ligand that determine biological function”,Seminars in Immunology, 6:267-278 (1994).
Felgner, Philip L. et al., “Improved Cationic Lipid Formulations for in Vivo Gene Therapy”,Ann. N. Y. Acad. Sci., 772:126-139 (1995).
Fisher, Lisa J. et al., “In vivo and ex vivo gene transfer to the brain”,Current Opinion in Neurobiology, 4:735-741 (1994).
Flotte, T. R. et al., “Adeno-associated virus vectors for gene therapy”,Gene Therapy, 2:357-362 (1995).
Furth, Priscilla A. et al., “Gene Transfer into Mammalian Cells by Jet Injection”,Hybridoma, 14:149-152 (1995).
Galle, Peter R. et al., “Involvement of the CD95 (APO-1/Fas) Receptor and Ligand in Liver Damage”,J. Exp. Med., 182:1223-1230 (1995).
Glorioso, J. C. et al., “Development and application of herpes simplex virus vectors for human gene therapy”,Annu. Rev. Microbiol., 49:675-710 (1995).
Goldspiel, Barry R. et al., “Human gene therapy”,Clinical Pharmacy, 12:488-505 (1993).
Graha

Affiliated with

Also associated with

Rating

Nucleic acids encoding chimeric CD154 polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acids encoding chimeric CD154 polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acids encoding chimeric CD154 polypeptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2683520